1318133-08-2

Upstream product

• 1318133-02-6 (4-chlorothieno[3,2-d]pyrimidine-7-yl)methanol 
• 1318133-04-8 4-chlorothieno[3,2-d]pyrimidine-7-carbaldehyde 
• 1318133-00-4 (4-chlorothieno[3,2-d]pyrimidine-7-yl)methyl acetate 
• 175137-21-0 4-chloro-7-methylthieno[3,2-d]pyrimidine 
• 175137-13-0 7-methyl-3,4-dihydrothieno[3,2-d]pyrimidin-4-one 
• 1269667-57-3 4-chlorothieno[3,2-d]pyrimidine-7-carboxylic acid 
• 209286-57-7 7-(bromomethyl)-4-chlorothieno[3,2-d]pyrimidine 
• 85006-31-1 3-amino-4-methyl-2-thiophenecarboxylic acid methyl ester 
• 10272-07-8 3.5-dimethoxyaniline 

Downstream Products

• 1318130-12-9 N-(4-bromo-2,6-dichloro-3,5-dimethoxyphenyl)-4-chlorothieno[3,2-d]pyrimidine-7-carboxamide 
• 1318131-14-4 N-(4-bromo-2,6-dichloro-3,5-dimethoxyphenyl)-4-(4-(4-ethylpiperazin-1-yl)benzamido)thieno[3,2-d]pyrimidine-7-carboxamide 

Relevant academic research and scientific papers

BICYCLIC HETEROARYL DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASE

The present invention relates to a novel bicyclic heteroaryl derivative, a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof having an improved inhibitory activity for protein kinases, and a pharmaceutical composition for preventing or treating an abnormal cell growth disorder comprising same as an active ingredient.

BICYCLIC HETEROARYL DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASE

The present invention relates to a novel bicyclic heteroaryl derivative, a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof having an improved inhibitory activity for protein kinases, and a pharmaceutical composition for preventing or treating an abnormal cell growth disorder comprising same as an active ingredient.